🔎 Trials Near Me

Akèy › Kansè trakt bilè › Maryland › Baltimore

Etid klinik pou Kansè trakt bilè nan Baltimore, MD

8 etid pou Kansè trakt bilè ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

Ap rekriteFaz 3
  • Research Site, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07221253

SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors

Ap rekriteFaz 1
  • United Theranostics, Glen Burnie · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07812805

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Ap rekriteFaz 3
  • Research Site, Towson · 8 mi lwen
Laj 18 a 99 · Tout sèks · Mizajou Aug 19, 2026 · NCT06467357

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Ap rekriteFaz 2
  • The John Hopkins Hospital, Baltimore
Laj 8 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05503797

Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)

Ap rekriteFaz 1
  • SKCCC Johns Hopkins Medical Institution, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou May 8, 2026 · NCT06564623

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

Ap rekriteFaz 2
  • University of Maryland Medical Center, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Apr 2, 2026 · NCT05733598

Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer

Ap rekriteFaz 1
  • Maryland Proton Treatment Center, Baltimore
  • University of Maryland Greenebaum Cancer Center, Baltimore
Laj 21 ak plis · Tout sèks · Mizajou Dec 10, 2025 · NCT06546969

Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers

Ap rekriteFaz 2
  • SKCCC Johns Hopkins, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Dec 3, 2025 · NCT06001658

Etid Kansè trakt bilè nan lòt vil

Lòt etid nan Baltimore

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.